Introduction To Moxifloxacin Compounds

Fluoroquinolone antibiotics. DNA topoisomerase inhibitors can be used to treat socially acquired pneumonia, acute attacks of chronic bronchitis, acute sinusitis, etc. caused by Staphylococcus aureus, influenza bacteria, pneumococcus, etc. It belongs to the fourth generation of quinolone antibiotics and is a new generation of broad-spectrum antibiotics. This product has strong antibacterial activity against common respiratory pathogens, such as Streptococcus pneumoniae, Haemophilus influenzae, Morahanum catarrhum, and some Staphylococcus aureus, especially against Streptococcus pneumoniae. Clinically used to treat acute sinusitis, acute attacks of chronic bronchitis, community acquired pneumonia, as well as uncomplicated skin infections and skin soft tissue infections. The characteristic of this product is that it has almost no photosensitive reaction, good tissue penetration, and can reach high concentrations in lung tissue. It is a good drug for treating respiratory infections.